Successful treatment of pure red cell aplasia with autologous stem cell transplantation

American Journal of Hematology

Volumn 82, Issue 9, 2007, Pages 812-814

  Park, Jae H ^a   Spitzer, Thomas ^a   Kuter, David J ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; PREDNISONE; RITUXIMAB; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CASE REPORT; DRUG MEGADOSE; DRUG WITHDRAWAL; ERYTHROCYTE APLASIA; ERYTHROCYTE TRANSFUSION; FEVER; HUMAN; HYPERTENSION; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; LEG THROMBOPHLEBITIS; MALE; PRIORITY JOURNAL; REMISSION; TREATMENT OUTCOME; VEIN THROMBOSIS; AUTOTRANSPLANTATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PURE RED CELL ANEMIA; RECURRENT DISEASE; STEM CELL TRANSPLANTATION; TIME;

FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RED-CELL APLASIA, PURE; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 35748984696     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20975     Document Type: Article

References (11)

1. Kadikoylu G, Bolaman Z, Barutca S. High-dose methylprednisolone therapy in pure red cell aplasia. Ann Pharmacother 2002;36:55-58.
2. Charles RJ, Sabo KM, Kidd PG, Abkowitz JL. The pathophysiology of pure red cell aplasia: Implications for therapy. Blood 1996;87:4831-4838.
3. Muller BU, Tichelli A, Passweg JR, Nissen C, Wodnar-Filipowicz A, Gratwohl A. Successful treatment for refractory acquired pure red cell aplasia by allogeneic bone marrow transplantation. Bone Marrow Transplant 1999;23:1205-1207.
4. Musso M, Porretto F, Crescimanno A, Polizzi V, Scalone R. Donor lymphocytic infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation. Bone Marrow Transplant 2004;33:769-771.
5. Tseng SB, Lin SF, Chang CS, Liu TC, Hsiao HH, Liu YC, et al. Successful treatment of acquired pure red cell aplasia by allogeneic peripheral blood stem cell transplantation. Am J Haematol 2003;74:273-275.
6. Passweg JR, Rabusin M, Musso M, Beguin Y, Cesaro S, Ehninger G, et al. Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. Br J Haematol 2004;125:749-755.
7. Marmont AM. Stem cell transplantation for severe autoimmune diseases: Progress and problems. Haematologica 1998;83:733-743.
8. Young NS, Maciejewski J. Mechanisms of disease: The pathophysiology of acquired aplastic anemia. N Engl J Med 1997;336:1365-1372.
9. Tyndall A, Fassas A, Passweg J, Ruiz de Elvira C, Attal M, Brooks P, et al. Autologous haematopoietic stem cell transplants for autoimmune disease-feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. Bone Marrow Transplant 1999;24:729-734.
10. Musso M, Porretto F, Crescimanno A. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. Am J Haematol 2001;66:75-79.
11. Burt RK, Traynor AE, Craig R, Marmont AM. The promise of hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 2003;31:521-524.